{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:11:01Z","timestamp":1790655061618,"version":"4.1.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Italian Ministry of Health","award":["Ricerca Corrente"],"award-info":[{"award-number":["Ricerca Corrente"]}]},{"DOI":"10.13039\/501100003407","name":"MIUR","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s40618-021-01635-z","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T21:02:55Z","timestamp":1626469375000},"page":"215-220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Class-specific responses of brown adipose tissue to steroidal and nonsteroidal mineralocorticoid receptor antagonists"],"prefix":"10.1007","volume":"45","author":[{"given":"V.","family":"Marzolla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Feraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Limana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Kolkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Armani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0722-7163","authenticated-orcid":false,"given":"M.","family":"Caprio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"1635_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.tem.2019.11.006","volume":"31","author":"A Feraco","year":"2020","unstructured":"Feraco A, Marzolla V, Scuteri A, Armani A, Caprio M (2020) Mineralocorticoid receptors in metabolic syndrome: From physiology to disease. Trends Endocrinol Metab 31:205\u2013217. https:\/\/doi.org\/10.1016\/j.tem.2019.11.006","journal-title":"Trends Endocrinol Metab"},{"key":"1635_CR2","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1096\/fj.13-245415","volume":"28","author":"A Armani","year":"2014","unstructured":"Armani A, Cinti F, Marzolla V, Morgan J, Cranston GA, Antelmi A, Carpinelli G, Canese R, Pagotto U, Quarta C, Malorni W, Matarrese P, Marconi M, Fabbri A, Rosano G, Cinti S, Morag JY, Caprio M (2014) Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice. FASEB J 28:3745\u20133757. https:\/\/doi.org\/10.1096\/fj.13-245415","journal-title":"FASEB J"},{"key":"1635_CR3","doi-asserted-by":"publisher","first-page":"12450","DOI":"10.1096\/fj.202000164R","volume":"34","author":"V Marzolla","year":"2020","unstructured":"Marzolla V, Feraco A, Gorini S, Mammi C, Marrese C, Mularoni V, Boitani C, Lombes M, Kolkhof P, Ciriolo MR, Armani A, Caprio M (2020) The novel non-steroidal mr antagonist finerenone improves metabolic parameters in high-fat diet-fed mice and activates brown adipose tissue via ampk-atgl pathway. FASEB J 34:12450\u201312465. https:\/\/doi.org\/10.1096\/fj.202000164R","journal-title":"FASEB J"},{"key":"1635_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3164\/jcbn.09-83","volume":"46","author":"JC Fraulob","year":"2010","unstructured":"Fraulob JC, Ogg-Diamantino R, Fernandes-Santos C, Aguila MB, Mandarim-de-Lacerda CA (2010) A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL\/6 Mice Fed a High Fat Diet. J Clin Biochem Nutr 46:212\u2013223. https:\/\/doi.org\/10.3164\/jcbn.09-83","journal-title":"J Clin Biochem Nutr"},{"key":"1635_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/dom.13539","volume":"21","author":"M Thuzar","year":"2019","unstructured":"Thuzar M, Law WP, Dimeski G, Stowasser M, Ho KKY (2019) Mineralocorticoid antagonism enhances brown adipose tissue function in humans: A randomized placebo-controlled cross-over study. Diabetes Obes Metab 21:509\u2013516. https:\/\/doi.org\/10.1111\/dom.13539","journal-title":"Diabetes Obes Metab"},{"key":"1635_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/eurheartj\/ehaa736","volume":"42","author":"R Agarwal","year":"2021","unstructured":"Agarwal R, Kolkhof P, Bakris G, Bauersachs J, Haller H, Wada T, Zannad F (2021) Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine. Eur Heart J 42:152\u2013161. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa736","journal-title":"Eur Heart J"},{"key":"1635_CR7","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A et al (2020) Effect of finerenone on chronic kidney disease outcomes in Type 2 diabetes. N Engl J Med 383:2219\u20132229. https:\/\/doi.org\/10.1056\/NEJMoa2025845","journal-title":"N Engl J Med"},{"key":"1635_CR8","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1161\/CIRCULATIONAHA.120.051898","volume":"143","author":"G Filippatos","year":"2021","unstructured":"Filippatos G, Anker SD, Agarwal R, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Schloemer P, Tornus I, Joseph A et al (2021) Finerenone and cardiovascular outcomes in patients with chronic kidney disease and Type 2 diabetes. Circulation 143:540\u2013552. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.051898","journal-title":"Circulation"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01635-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-021-01635-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01635-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T19:16:26Z","timestamp":1641582986000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-021-01635-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1635"],"URL":"https:\/\/doi.org\/10.1007\/s40618-021-01635-z","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]},"assertion":[{"value":"9 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"P.K. is a full-time employee of Bayer AG. M.C. received research grants from Bayer AG. The other authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Animal procedures were approved by the Italian National Institutes of Health Care and Use Committees (approval number 493\/2016-PR). In the present study we did not perform research involving human participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}